A new cell therapy center aims to strengthen Baltimore’s position in ‘DNA Valley’

Health care technology concept. Vital sign sensing.

Johns Hopkins Medicine and biotech company Orgenesis are partnering to launch the Maryland Center for Cell Therapy Manufacturing, supported by a $5 million matching grant from the State of Maryland.

The facility will close the loop on the biotech ecosystem in Maryland while allowing for lab and patient trials to be done in Baltimore instead of outsourced to another city, like Boston or Philadelphia, which would keep dollars flowing inside the city instead of leaving it.

Read the full article at


Technically Baltimore: Baltimore Homecoming’s Amplify 2022 is winding down, but it saved the tech for last

May 15, 2022
Since Wednesday, local economic and civic booster organization Baltimore Homecoming has been gathering the city’s most accomplished natives and expats for panels and curated field trips as part of Amplify...
Baltimore, Maryland, USA Inner Harbor Skyline Aerial.

Maryland Inno: Catalio Capital Management raises $381M fund — its largest yet

May 14, 2022
Life sciences investment firm Catalio Capital Management has raised nearly $400 million for its next fund, its third and largest venture fund yet. Read the full article here.

Be a community partner.

Learn More

US Tech Future is a Verizon-led community-focused initiative working to engage the local community in a discussion about technology and how it can improve the lives of local residents for their benefit and the benefit of the community as a whole.

Our mission is to engage with citizens and community stakeholders in USA to provide information on how technology can work to have a dramatic impact on the way we work and live in our communities.